v3.25.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit (Unaudited) - USD ($)
Successor
Convertible Preferred Stock
Series A
Successor
Convertible Preferred Stock
Series B
Successor
Convertible Preferred Stock
Series C
Successor
Common Stock
Series A
Successor
Additional Paid-in Capital
Successor
Stock Subscriptions Receivable
Successor
Accumulated Deficit
Successor
Predecessor
Convertible Preferred Stock
Series A
Predecessor
Convertible Preferred Stock
Series Seed
Predecessor
Common Stock
Predecessor
Additional Paid-in Capital
Predecessor
Accumulated Deficit
Predecessor
Balance at Dec. 31, 2022                 $ 38,023,784 $ 4,077,560   $ 929,464 $ (35,800,244) $ (34,870,780)
Balance (in Shares) at Dec. 31, 2022                 22,764,764 5,155,703 291      
Issuance of common stock from exercise of stock options                 5,766 5,766
Issuance of common stock from exercise of stock options (in Shares)                     1      
Stock-based compensation                 96,896 96,896
Net loss                 (7,289,577) (7,289,577)
Balance at Dec. 31, 2023                 $ 38,023,784 $ 4,077,560   1,032,126 (43,089,821) (42,057,695)
Balance (in Shares) at Dec. 31, 2023                 22,764,764 5,155,703 292      
Stock-based compensation                 4,431 4,431
Net loss                 (572,211) (572,211)
Balance at Feb. 13, 2024 $ 8,937,852 $ 1 $ 53,899,885 $ (2,000,000) $ (63,185,641) $ (2,347,903) $ 38,023,784 $ 4,077,560   1,036,557 (43,662,032) (42,625,475)
Balance (in Shares) at Feb. 13, 2024 10,089 7,266         22,764,764 5,155,703 292      
Balance at Dec. 31, 2023                 $ 38,023,784 $ 4,077,560   1,032,126 (43,089,821) (42,057,695)
Balance (in Shares) at Dec. 31, 2023                 22,764,764 5,155,703 292      
Balance at Dec. 31, 2024 $ 1,708,396 $ 218,051 $ 1,249,999 $ 12 67,142,276 (1,295,444) (70,917,853) (1,894,563)            
Balance (in Shares) at Dec. 31, 2024 1,894 273 2,853 120,794                    
Balance at Feb. 13, 2024 $ 8,937,852 $ 1 53,899,885 (2,000,000) (63,185,641) (2,347,903) $ 38,023,784 $ 4,077,560   1,036,557 (43,662,032) (42,625,475)
Balance (in Shares) at Feb. 13, 2024 10,089 7,266         22,764,764 5,155,703 292      
Balance at Feb. 13, 2024 $ 8,937,852 $ 1 53,899,885 (2,000,000) (63,185,641) (2,347,903) $ 38,023,784 $ 4,077,560   1,036,557 (43,662,032) (42,625,475)
Balance (in Shares) at Feb. 13, 2024 10,089 7,266         22,764,764 5,155,703 292      
Issuance of Series B shares sold to investors $ 500,000 (500,000)            
Issuance of Series B shares sold to investors (in Shares)   626                        
Stock-based compensation 96,289 96,289            
Net loss (1,727,483) (1,727,483)            
Balance at Mar. 31, 2024 $ 8,937,852 $ 500,000 $ 1 53,996,174 (2,500,000) (64,913,124) (3,979,097)            
Balance (in Shares) at Mar. 31, 2024 10,089 626 7,266                    
Balance at Feb. 13, 2024 $ 8,937,852 $ 1 53,899,885 (2,000,000) (63,185,641) (2,347,903) $ 38,023,784 $ 4,077,560   $ 1,036,557 $ (43,662,032) $ (42,625,475)
Balance (in Shares) at Feb. 13, 2024 10,089 7,266         22,764,764 5,155,703 292      
Issuance of shares of Series A Preferred Stock upon exercise of Series A Preferred Warrants $ 1,529,493 (1,507,600) 1,507,600 1,529,493            
Issuance of shares of Series A Preferred Stock upon exercise of Series A Preferred Warrants (in Shares) 1,875                          
Purchases of shares of Common Stock under Keystone ELOC $ 2 4,809,701 (716,694) 4,093,009            
Purchases of shares of Common Stock under Keystone ELOC (in Shares)       22,675                    
Issuance of shares of Common Stock upon conversion of Series A Preferred Stock $ (8,760,824) $ 9 8,760,815            
Issuance of shares of Common Stock upon conversion of Series A Preferred Stock (in Shares) (10,073)     86,194                    
Issuance of shares of Common Stock upon conversion of Series B Preferred Stock $ (281,949) 281,949            
Issuance of shares of Common Stock upon conversion of Series B Preferred Stock (in Shares) (353) 2,691                    
Issuance of shares of Series C Preferred Stock sold to investors, net of issuance costs of $446,438 $ 1,249,999 (446,438) 803,561            
Issuance of shares of Series C Preferred Stock sold to investors, net of issuance costs of $446,438 (in Shares)     2,853                      
Subscription receivable for share issued in advance 86,350 (86,350)            
Subscription receivable for share issued in advance (in Shares)       863                    
Deemed dividend – common stock liability, 13,835 shares (85,500) (85,500)            
Issuance of Series B shares sold to investors $ 500,000     (81,684)   418,316            
Issuance of Series B shares sold to investors (in Shares)   626                        
Issuance of Series A shares for rounding purchases $ 1,875   130   2,005            
Issuance of Series A shares for rounding purchases (in Shares) 3                          
Issuance of common stock for Arena Equity Line of Credit (ELOC) commitment fee   500,000   500,000            
Issuance of common stock for Arena Equity Line of Credit (ELOC) commitment fee (in Shares)       173                    
Issuance of shares of Common Stock for Keystone ELOC commitment fee              
Issuance of shares of Common Stock for Keystone ELOC commitment fee (in Shares)       932                    
Stock-based compensation 924,668 924,668            
Net loss (7,732,212) (7,732,212)            
Balance at Dec. 31, 2024 $ 1,708,396 $ 218,051 $ 1,249,999 $ 12 67,142,276 (1,295,444) (70,917,853) (1,894,563)            
Balance (in Shares) at Dec. 31, 2024 1,894 273 2,853 120,794                    
Issuance of shares of Series A Preferred Stock upon exercise of Series A Preferred Warrants $ 500,000 (500,000) 500,000 500,000            
Issuance of shares of Series A Preferred Stock upon exercise of Series A Preferred Warrants (in Shares) 625                          
Sale of common stock $ 2 587,998 588,000            
Sale of common stock (in Shares)       15,000                    
Sale of pre-funded warrants, net of issuance costs of $839,004 3,572,795 3,572,795            
Exercise of pre-funded warrants $ 9 173     182            
Exercise of pre-funded warrants (in Shares)       91,214                    
Purchases of shares of Common Stock under Keystone ELOC $ 1 1,227,240 1,227,241            
Purchases of shares of Common Stock under Keystone ELOC (in Shares)       14,531                    
Collection of stock subscriptions receivable related to prior Keystone ELOC purchases 716,694 716,694            
Issuance of shares of Common Stock upon conversion of Series A Preferred Stock $ (921,081) $ 1 921,080            
Issuance of shares of Common Stock upon conversion of Series A Preferred Stock (in Shares) (1,090)     14,447                    
Issuance of shares of Common Stock upon conversion of Series B Preferred Stock $ (59,904) 59,904            
Issuance of shares of Common Stock upon conversion of Series B Preferred Stock (in Shares) (75) 2,500                    
Redemption of Series C Preferred Stock $ (267,856) (127,144) (395,000)            
Redemption of Series C Preferred Stock (in Shares)     (316)                      
Share-based inducement expense related to conversion of Series A Preferred Stock 156,250 156,250            
Stock-based compensation 304,946 304,946            
Net loss (5,105,931) (5,105,931)            
Balance at Mar. 31, 2025 $ 1,287,315 $ 158,147 $ 982,143 $ 25 $ 73,345,518 $ (78,750) $ (76,023,784) $ (329,386)            
Balance (in Shares) at Mar. 31, 2025 1,429 198 2,537 258,486